 Home > Pharmaceutical Intermediates > Antineoplastics > Dasatinib for Sale > Dasatinib - Multi-Targeted Kinase Inhibitor API for Hematologic Malignancies.

Dasatinib - Multi-Targeted Kinase Inhibitor API for Hematologic Malignancies. buy - large image1

Dasatinib - Multi-Targeted Kinase Inhibitor API for Hematologic Malignancies. buy - image1

Dasatinib - Multi-Targeted Kinase Inhibitor API for Hematologic Malignancies. buy - image2

Dasatinib - Multi-Targeted Kinase Inhibitor API for Hematologic Malignancies. buy - image3

Dasatinib - Multi-Targeted Kinase Inhibitor API for Hematologic Malignancies.

Name: Dasatinib - Multi-Targeted Kinase Inhibitor API for Hematologic Malignancies.
Brand: Tianrui
SKU: pr2511131378
Price: 11 USD
Availability: InStock

4 Inquiries

Unit Price: Get Latest Price 

CAS No.:

302962-49-8

Grade:

Pharmaceutical Grade

Content:

98.5%

Port:

Qingdao

Brand:

Tianrui

Packaging:

Sealed fiber drum

Price valid (until):

2025-11-12

Contact Supplier

 Chat Now

Hefei Tianrui Pharmaceutical Chemical Co., Ltd.

Company Type:

Manufactory

Location:

China

Qualification:

Main Products:

APIs

 Visit Store

Product Description
Seller Information
Inquiry History

Description

About Product

Macitentan (CAS: 441798-33-0) is a high-purity active pharmaceutical ingredient (API) that functions as a dual endothelin receptor antagonist. Specifically developed for the treatment of pulmonary arterial hypertension (PAH), it demonstrates improved efficacy in delaying disease progression. Manufactured by Hefei TianRui Pharmaceutical under cGMP conditions, our Macitentan API guarantees high purity, low impurity profiles, and reliable quality for cardiovascular drug formulations.

Items	Specifications
Product Name	Dasatinib
CAS Registry Number	302962-49-8
IUPAC Name	N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
Molecular Weight	488.01 g/mol
Solubility	It is soluble in DMSO, soluble in methanol, and slightly soluble in water.
Melting Point	280-283°C
Primary Use	Chronic Myeloid Leukemia (CML) Acute Lymphoblastic Leukemia (ALL) For leukemia that is resistant to other treatments

Shop Roflumilast API - A Selective PDE4 Inhibitor for COPD Maintenance Treatment.-Detailed Image 1

Shop Roflumilast API - A Selective PDE4 Inhibitor for COPD Maintenance Treatment.-Detailed Image 2

Shop Roflumilast API - A Selective PDE4 Inhibitor for COPD Maintenance Treatment.-Detailed Image 3

Company Profile

Founded: 2014
Focus: High-tech enterprise specializing in the development and industrialization of small-molecule pharmaceutical synthesis technology
Facilities:
- Two workshops (TR1 & TR2) with total capacity ≈ 1000 tons/year
- Reactors: 3000L×15, 2000L×10, and numerous smaller reactors (1000L, 500L, 100L)
- Ultra-low temperature cryogenic reactor (explosion-proof workshop included)
- GMP workshop & clean room
QC Lab Equipment: GC×2, HPLC×3, UV, IR, KF titrator, etc.

About company

Shop Roflumilast API - A Selective PDE4 Inhibitor for COPD Maintenance Treatment.-Detailed Image 7

In 2015, the company developed polypeptide absorbent permeation enhancers: ethyl 8-bromo-octanoate and Carsalam, which is the 1st and only qualified Chinese supplier of Semaglutide to meet the internal control requirements of innovator Novo Nordisk.

In 2020, the company independently developed and optimized 8-bromo-octanoic acid and 6-bromo-caproic acid to become a COVID-19 vaccine carrier manufacturer and supplier to Moderna company, contributing its share to the fight against COVID-19.

In 2022, Tianrui R&D Center and cGMP manufacturing facility was inaugurated and put into operation. And in the same year, polypeptide absorbent permeation enhancers SNAC (Salcaprozate Sodium) has successfully obtained the domestic CDE registration number (F20220000072) and the US FDA registration number (037135), and another batch of innovative APIs and pharmaceutical excipients are under registration and approval.

Basic Info

Product Name:

Dasatinib

Other Name:

5-Thiazolecarboxamide,N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide;BMS 354825;Dasatinib;BMS 35482513;Sprycel;Spyrcel;BMS 345825;KIN 001-5;NSC 759877

CAS No.:

302962-49-8

Molecular Formula:

C22H26ClN7O2S

InChIKeys:

InChIKey=ZBNZXTGUTAYRHI-UHFFFAOYSA-N

Molecular Weight:

488.007

Exact Mass:

488.01

EC Number:

801-607-0

UNII:

X78UG0A0RN

NSC Number:

759877|732517

DSSTox ID:

DTXSID4040979

NCI Thesaurus Code:

C74556

ATC Code:

L01EA02|L01XE06|L - Antineoplastic and immunomodulating agents

HScode:

29341000

Categories:

Antineoplastics

Characteristics

PSA:

135

XLogP3:

3.6

Appearance:

Solid

Density:

1.4±0.1 g/cm3

Melting Point:

280 - 286 °C

Refractive Index:

1.688

Water Solubility:

1.28e-02 g/L

See More Dasatinib Properties 

Hazard Identification

Classification of the substance or mixture

Acute toxicity - Category 3, Oral

Skin irritation, Category 2

Serious eye damage, Category 1

Carcinogenicity, Category 2

Reproductive toxicity, Category 2

Specific target organ toxicity â repeated exposure, Category 1

Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 1

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)
Signal word	Danger
Hazard statement(s)	H301 Toxic if swallowed H315 Causes skin irritation H318 Causes serious eye damage H351 Suspected of causing cancer H361 Suspected of damaging fertility or the unborn child H372 Causes damage to organs through prolonged or repeated exposure H410 Very toxic to aquatic life with long lasting effects
Prevention	P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/... P203 Obtain, read and follow all safety instructions before use. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P273 Avoid release to the environment.
Response	P301+P316 IF SWALLOWED: Get emergency medical help immediately. P321 Specific treatment (see ... on this label). P330 Rinse mouth. P302+P352 IF ON SKIN: Wash with plenty of water/... P332+P317 If skin irritation occurs: Get medical help. P362+P364 Take off contaminated clothing and wash it before reuse. P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P317 Get medical help. P318 IF exposed or concerned, get medical advice. P319 Get medical help if you feel unwell. P391 Collect spillage.
Storage	P405 Store locked up.
Disposal	P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More Dasatinib Safety Data Sheet 

Seller Information

Business Type:
Manufactory

Main Products:
APIs

Location:
No.23,lntersection of Fenglehe Avenue and Leiyang Road, Huagang Town,Feixi County, Hefei, Anhui, China.

Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
15

Total Annual Revenue:
$50 million-$100 million

Total Employees:
11-50

Year of Establishment:
2014

About TianRui

Hefei TianRui Pharmaceutical Chemical Co., Ltd was founded in 2014 as a high-tech enterprise focused on the development and industrialization of pharmaceutical small molecule synthesis technology. Our workshop and R&D center are located in Hefei HuaGang Provincial Industrial Park, Anhui Province. We are committed to providing professional technical services and commercialization of small molecule specialty APIs, CGMP standard intermediates, and functional pharmaceutical excipients and MRNA vaccine vectors for domestic and overseas well-known pharmaceutical companies.

Main Events

In 2015, the company developed polypeptide absorbent permeation enhancers: ethyl 8-bromo-octanoate and Carsalam, which is the 1st and only qualified Chinese supplier of Semaglutide to meet the internal control requirements of innovator Novo Nordisk.

In 2020, the company independently developed and optimized 8-bromo-octanoic acid and 6-bromo-caproic acid to become a COVID-19 vaccine carrier manufacturer and supplier to Moderna company, contributing its share to the fight against COVID-19.

In 2022, Tianrui R&D Center and cGMP manufacturing facility was inaugurated and put into operation. And in the same year, polypeptide absorbent permeation enhancers SNAC (Salcaprozate Sodium) has successfully obtained the domestic CDE registration number (F20220000072) and the US FDA registration number (037135), and another batch of innovative APIs and pharmaceutical excipients are under registration and approval.

Inquiry History

4 Inquiries

Country	Product	Purchase Quantity	Date Posted
Pakistan	DASATINIB	500 G	Aug 29, 2025
Jordan	Dasatinib	1.00 KG	Sep 20, 2023
Canada	Dasatinib	500 MG	Mar 4, 2025
India	Dasatinib	100.00 KG	Nov 7, 2023

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
Dasatinib(BMS-354825)	/99		Creative Enzymes	Inquiry
Dasatinib	/		Hangzhou Dawn Ray Pharmaceutical Co.,Ltd	Inquiry
High Potent Antineoplastic Small Molecule Dasatinib Bulk Powder for Oncology Research CAS 302962-49-8	Pharmaceutical Grade/99	$5-6/MT FOB	Hangzhou Hyper Chemicals Limited	Inquiry
Dasatinib 99% white powder 302962-49-8 Senwayer	Pharmaceutical Grade/99		Dingwang Technology (Wuhan) Co., Ltd.	Inquiry
Dasatinib	/99.00		HANGZHOU LEAP CHEM CO., LTD.	Inquiry